OAKLAND, Calif. -- Kaiser Permanente researchers presented the results of four years' study of Prevnar, a pneumococcal vaccine effective against seven types of pneumococcal disease, at the Society for Pediatric Research conference in San Francisco last week.
Drs. Henry Shinefield and Steve Black followed Kaiser Permanente patients
from before children received the vaccine in 2000 up to March 2004.
Their data show that even unvaccinated adults and older children are
experiencing lower rates of pneumococcal disease since the vaccine's
introduction. Reduction of invasive pneumococcal disease was 52 percent in
children aged five to 19; 46 percent in people aged 20 to 39; 23 percent in
those 40 to 59; and 32 percent for adults 60 and over.
"We're excited by these findings," says Shinefield. "Truly, this is
an effect we hadn't expected -- that the vaccine would reduce the rate of
disease even in people who hadn't gotten it. It's clear that vaccinating
children diminishes the circulation of the pneumococcus in the environment,
prevents serious bacterial disease in infants and toddlers, and protects the
rest of the population as well."
The study also found that since the vaccine's introduction
penicillin-resistant pneumococcal infection has dropped from a high of 15
percent of all cases in 2000 to 5 percent in 2003.
"The decrease in penicillin resistance is related to the decrease in the
community of the seven penicillin-resistant pneumococcal types present in the
vaccine," says Shinefield.
Pneumococcus can cause pneumonia, meningitis and bacteremia -- an
infection of the bloodstream -- in children and adults. The fatality rate of
these diseases can go as high as 50 percent among adults. Immuno-compromised
adults and smokers carry higher risks of contracting the diseases.
In Kaiser Permanente's study, funded by the manufacturers of the vaccine,
Wyeth Inc., 37,868 children were vaccinated at two, four and six months, with
a booster at 12 to 15 months. The randomized controlled trial, completed in
1999, looked at incidences of invasive pneumococcal disease, and at otitis
media and pneumonia. The current report highlights the striking reduction of invasive pneumococcal disease in approximately 150,000 vaccinated and unvaccinated children under 5 years of age, as well the effects of the vaccine on the entire Kaiser Permanente Northern California population of more than 3 million.
Source: Kaiser Permanente
Product Locator: Spring and Early Mother's Day Gift Guide for Infection Prevention Personnel
March 27th 2024Whether it's a spring holiday, birthdays, or no reason at all, infection prevention personnel love to give and receive gifts that help at the end of a stressful day. Infection Control Today® offers some gift ideas for infection prevention personnel and their families.
Catching Up With Vangie Dennis, AORN 2022-2023 President at AORN 2024
March 26th 2024Infection Control Today (ICT) had the privilege of catching up with Vangie Dennis, MSN, RN, CNOR, CMLSO, at the Association of periOperative Registered Nurses' (AORN’s) International Surgical Conference & Expo 2024. As the former president of AORN and an esteemed figure in perioperative services, Vangie Dennis shared insights into her recent endeavors and the exciting new chapter she's embarked upon.
How To Optimize Your Time Management Strategies for the Busy Infection Preventionist
March 25th 2024Is your calendar resembling a chaotic masterpiece of overlapping tasks? Join the club of infection preventionists striving to balance responsibilities. Dive into proven strategies from a fellow infection preventionist to reclaim control of your time, streamline tasks, and boost productivity effectively. This is an IP Lifeline article.
CenTrak Unveils Revolutionary BLE Multi-Mode Platform for Health Care RTLS Solutions
March 22nd 2024CenTrak, the industry leader in real-time location technology, introduces the groundbreaking BLE Multi-Mode Platform, setting a new standard for Real-Time Location Systems (RTLS) in health care. Discover how this innovative solution enhances location data precision and streamlines operations for health care organizations.